Neutralizing antibodies against coronaviruses
Pamela Bjorkman, Ph.D., David Baltimore Professor of Biology and Biological Engineering, Merkin Institute Professor, Division of Biology and Biological Engineering- California Institute of Technology
Pamela Bjorkman, Ph.D., David Baltimore Professor of Biology and Biological Engineering, Merkin Institute Professor, Division of Biology and Biological Engineering- California Institute of Technology
Dusan Bogunovic, Ph.D., Associate Professor, Director- Center for Inborn Errors of Immunity, Precision Immunology Institute, Mindich Child Health and Development Institute Department of Microbiology, Department of Pediatrics- Icahn School of Medicine at Mount Sinai
Kerry Reynolds, M.D., Clinical Director, Inpatient Oncology, Director, Severe Immunotherapy Complications Service, Massachusetts General Hospital Cancer Center, Assistant Professor of Medicine, Harvard Medical School
Samuel Vidal
Sam Vidal, M.D., Ph.D., Research Fellow, Barouch Lab, Center for Virology and Vaccine Research. Clinical Fellow, Mass General Brigham Infectious Diseases Program
Sylvie Mader, Ph.D., Professor, Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Biology, Université de Montréal
T.-C. Wu, M.D., Ph.D., Professor and Director of Gynecologic Pathology, Professor of Oncology, Obstetrics & Gynecology, and Molecular Microbiology & Immunology, Johns Hopkins University, Daniel Nathans Scholar, Academician, Academia Sinica
Michael M. Lederman M.D., LSMFT, Professor of Medicine. Professor of Pathology, Microbiology/Molecular Biology- Case Western Reserve University. Editor-in-Chief Pathogens and Immunity
James L. Riley, Ph.D., Professor of Microbiology, Perelman School of Medicine- University of Pennsylvania
Peter W. Hunt, M.D., Professor, Division of Experimental Medicine, Department of Medicine- University of California San Francisco; Co-Director of the UCSF-Bay Area CFAR for Basic and Translational Science